This securities fraud class action alleges that Globus, a medical device company, failed to disclose (1) its relationship with a significant distributor was deteriorating; (2) the deterioration negatively impacted Globus’s financial performance; and (3) as a result, Globus’s prospects and statements were false and misleading.
Read more